Literature DB >> 16924469

Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1.

Ferruh Artunc1, Kerstin Amann, Omaima Nasir, Björn Friedrich, Diana Sandulache, Nermina Jahovic, Teut Risler, Volker Vallon, Peer Wulff, Dietmar Kuhl, Florian Lang.   

Abstract

Mineralocorticoids stimulate renal tubular Na(+) reabsorption, enhance salt appetite, increase blood pressure, and favor the development of renal fibrosis. The effects of mineralocorticoids on renal tubular Na(+) reabsorption and salt appetite involve the serum- and glucocorticoid-inducible kinase 1 (SGK1). The kinase is highly expressed in fibrosing tissue. The present experiments thus explored the involvement of SGK1 in renal fibrosis. To this end, SGK1-knockout mice (sgk1 (-/-)) and their wild-type littermates (sgk1 (+/+)) were implanted with desoxycorticosterone acetate (DOCA)-release pellets and offered 1% saline as drinking water for 12 weeks. The treatment led to significant increases in fluid and Na(+) intake and urinary output of fluid and Na(+) in sgk1 (+/+) mice, effects blunted in sgk1 (-/-) mice. Blood pressure increased within the first 7 weeks to a similar extent in both genotypes, but within the next 5 weeks, it increased further only in sgk1 (+/+) mice. Creatinine clearance did not change significantly but albuminuria increased dramatically in sgk1 (+/+) mice, an effect significantly blunted in sgk1 (-/-) mice. Histology after 12 weeks treatment revealed marked glomerular sclerosis and tubulointerstitial damage with interstitial fibrosis and inflammation in kidneys from sgk1 (+/+) mice, but not from sgk1 (-/-) mice. In conclusion, a lack of SGK1 protects against DOCA/high-salt-induced albuminuria and renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924469     DOI: 10.1007/s00109-006-0082-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  58 in total

Review 1.  Renal physiology of the mouse.

Authors:  P Meneton; I Ichikawa; T Inagami; J Schnermann
Journal:  Am J Physiol Renal Physiol       Date:  2000-03

2.  Excessive transcription of the human serum and glucocorticoid dependent kinase hSGK1 in lung fibrosis.

Authors:  Simone Waerntges; Karin Klingel; Cora Weigert; Sophie Fillon; Miriam Buck; Erwin Schleicher; Hans P Rodemann; Cornelius Knabbe; Reinhard Kandolf; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2002

Review 3.  SGK1 regulation of epithelial sodium transport.

Authors:  David Pearce
Journal:  Cell Physiol Biochem       Date:  2003

4.  SGK1-mediated fibronectin formation in diabetic nephropathy.

Authors:  Yuxi Feng; Quansheng Wang; Yumei Wang; Benito Yard; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2005

5.  The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.

Authors:  M J Young; J W Funder
Journal:  Am J Physiol       Date:  1996-11

6.  Cell surface expression of the ROMK (Kir 1.1) channel is regulated by the aldosterone-induced kinase, SGK-1, and protein kinase A.

Authors:  Dana Yoo; Bo Young Kim; Cristina Campo; Latreece Nance; Amanda King; Djikolngar Maouyo; Paul A Welling
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

7.  SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess.

Authors:  Volker Vallon; Dan Yang Huang; Florian Grahammer; Amanda W Wyatt; Hartmut Osswald; Peer Wulff; Dietmar Kuhl; Florian Lang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-08       Impact factor: 3.619

8.  Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.

Authors:  Marcus Quinkler; Daniel Zehnder; Kevin S Eardley; Julia Lepenies; Alexander J Howie; Susan V Hughes; Paul Cockwell; Martin Hewison; Paul M Stewart
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

9.  Down-regulation of calpain 9 is linked to hypertensive heart and kidney disease.

Authors:  André Markmann; Stefan Schäfer; Wolfgang Linz; Matthias Löhn; Andreas E Busch; Paulus Wohlfart
Journal:  Cell Physiol Biochem       Date:  2005

10.  Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.

Authors:  Anette Fiebeler; Jürg Nussberger; Erdenechimeg Shagdarsuren; Song Rong; Georg Hilfenhaus; Nidal Al-Saadi; Ralf Dechend; Maren Wellner; Silke Meiners; Christiane Maser-Gluth; Arco Y Jeng; Randy L Webb; Friedrich C Luft; Dominik N Muller
Journal:  Circulation       Date:  2005-06-06       Impact factor: 29.690

View more
  19 in total

Review 1.  Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.

Authors:  Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2010-06-09       Impact factor: 2.801

2.  The serum- and glucocorticoid-induced kinase in DOCA-salt hypertension.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2006-08-08       Impact factor: 4.599

3.  Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.

Authors:  Wakako Kawarazaki; Miki Nagase; Shigetaka Yoshida; Maki Takeuchi; Kenichi Ishizawa; Nobuhiro Ayuzawa; Kohei Ueda; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

4.  SGK1 is not required for regulation of colonic ENaC activity.

Authors:  Rexhep Rexhepaj; Ferruh Artunc; Florian Grahammer; Omaima Nasir; Ciprian Sandu; Björn Friedrich; Dietmar Kuhl; Florian Lang
Journal:  Pflugers Arch       Date:  2006-08-08       Impact factor: 3.657

5.  What level of sodium intake worsens renal outcomes?

Authors:  Michael S Lipkowitz; Christopher S Wilcox
Journal:  Am J Hypertens       Date:  2014-05-10       Impact factor: 2.689

Review 6.  Aldosterone-induced fibrosis in the kidney: questions and controversies.

Authors:  Andrew S Brem; David J Morris; Rujun Gong
Journal:  Am J Kidney Dis       Date:  2011-06-25       Impact factor: 8.860

Review 7.  Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport.

Authors:  Florian Lang; Volker Vallon
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

8.  SGK, renal function and hypertension.

Authors:  Florian Lang; Dan Yang Huang; Volker Vallon
Journal:  J Nephrol       Date:  2010 Nov-Dec       Impact factor: 3.902

9.  Aldosterone activates NF-kappaB in the collecting duct.

Authors:  Valérie Leroy; Sophie De Seigneux; Victor Agassiz; Udo Hasler; Marie-Edith Rafestin-Oblin; Manlio Vinciguerra; Pierre-Yves Martin; Eric Féraille
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

Review 10.  Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.

Authors:  Nancy J Brown
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.